Karyopharm Therapeutics Inc (KPTI)

Nov 18, 2024

Karyopharm to Present New Selinexor Clinical Data at ASH 2024 Annual Meeting | KPTI Stock News - StockTitan

Nov 18, 2024

Nov 15, 2024

Avidity Partners Management LP's Strategic Acquisition of Karyop - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress By Investing.com - Investing.com Nigeria

Nov 14, 2024

Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress - Investing.com India

Nov 14, 2024

Nov 14, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Rating Upgraded by StockNews.com - MarketBeat

Nov 14, 2024

Nov 14, 2024

GSA Capital Partners LLP Purchases 792,283 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat

Nov 14, 2024

Nov 08, 2024

Leerink Partnrs Issues Optimistic Forecast for KPTI Earnings - MarketBeat

Nov 08, 2024

Nov 08, 2024

What is HC Wainwright's Estimate for KPTI FY2024 Earnings? - MarketBeat

Nov 08, 2024

Nov 08, 2024

Karyopharm Therapeutics Falls To US$0.88, But Insiders Sold At Lower Price - Simply Wall St

Nov 08, 2024

Nov 08, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

Nov 08, 2024

Nov 08, 2024

Karyopharm Therapeutics Reports Q3 2024 Financial Results and Corporate Progress - Defense World

Nov 08, 2024

Nov 07, 2024

Karyopharm Therapeutics Inc (KPTI) Is Worth Accumulating At Current Levels - Stocks Register

Nov 07, 2024

Nov 07, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Nov 06, 2024

Karyopharm stock price target raised, overweight on revenue beat - Investing.com India

Nov 06, 2024

Nov 06, 2024

Karyopharm therapeutics CEO Richard Paulson sells $3,346 in stock - Investing.com

Nov 06, 2024

Nov 06, 2024

Karyopharm therapeutics CEO Richard Paulson sells $3,346 in stock By Investing.com - Investing.com Canada

Nov 06, 2024

Nov 06, 2024

Karyopharm stock price target raised, overweight on revenue beat By Investing.com - Investing.com Australia

Nov 06, 2024

Nov 06, 2024

Earnings call: Karyopharm Therapeutics reports on clinical and financial progress - Investing.com Nigeria

Nov 06, 2024

Nov 06, 2024

Piper Sandler Boosts Karyopharm Therapeutics (NASDAQ:KPTI) Price Target to $5.00 - MarketBeat

Nov 06, 2024

Nov 06, 2024

Karyopharm price target raised to $5 from $4 at Piper Sandler - TipRanks

Nov 06, 2024

Nov 06, 2024

Karyopharm Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlig - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

Karyopharm Therapeutics' SWOT analysis: oncology firm's stock faces pivotal year - Investing.com Australia

Nov 06, 2024

Nov 06, 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

Karyopharm Therapeutics Inc. Reports Q3 2024 Earnings - TipRanks

Nov 05, 2024

Nov 05, 2024

Karyopharm Therapeutics Q3 2024 Earnings Preview - MSN

Nov 05, 2024

Nov 05, 2024

Karyopharm Therapeutics (KPTI) Q3 2024 Earnings Call Transcript - AOL

Nov 05, 2024

Nov 05, 2024

Karyopharm Therapeutics: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 05, 2024

Nov 05, 2024

Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 05, 2024

Nov 05, 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings: EPS Loss of - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

Karyopharm Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 05, 2024

Nov 05, 2024

Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress - PR Newswire

Nov 05, 2024

Nov 04, 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com

Nov 04, 2024

Nov 02, 2024

KPTIKaryopharm Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Nov 02, 2024

Nov 02, 2024

Karyopharm Therapeutics (KPTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - MSN

Nov 02, 2024

Nov 01, 2024

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - WV News

Nov 01, 2024

Nov 01, 2024

Karyopharm Therapeutics (KPTI) to Release Quarterly Earnings on Tuesday - MarketBeat

Nov 01, 2024

Nov 01, 2024

Karyopharm Therapeutics' (KPTI) Buy Rating Reiterated at HC Wainwright - MarketBeat

Nov 01, 2024

Nov 01, 2024

Karyopharm updates SENTRY trial endpoints, eyes 2025 data - Investing.com India

Nov 01, 2024

Oct 31, 2024

Karyopharm updates SENTRY trial endpoints, eyes 2025 data By Investing.com - Investing.com Canada

Oct 31, 2024

Oct 31, 2024

Karyopharm gains after changes to late-stage trial - MSN

Oct 31, 2024

Oct 31, 2024

Karyopharm stock gains as late-stage trial changes (KPTI:NASDAQ) - Seeking Alpha

Oct 31, 2024

Oct 31, 2024

Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024 - StockTitan

Oct 31, 2024

Oct 31, 2024

Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis - Kilgore News Herald

Oct 31, 2024

Oct 30, 2024

Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024 - Investor Relations | Karyopharm Therapeutics

Oct 30, 2024

Oct 30, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Share Price Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat

Oct 30, 2024